^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
DCTY0801
i
Other names: DCTY0801, EGFRvIII CAR-T
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Beijing DCTY Biotech
Drug class:
EGFRvIII-targeted CAR-T immunotherapy
Related drugs:
